Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

Towards an ideal source of mesenchymal stem cell isolation for possible therapeutic application in regenerative medicine.

Bellavia M., Altomare R., Cacciabaudo F., Santoro A., Allegra A., Concetta Gioviale M.

Narrative Review, published in Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2013) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2013)
Country
Czech Republic
Reported sample size
—
Source database
PubMed
PMID
23945846
DOI
10.5507/bp.2013.051

Abstract (original English)

The possibility of obtaining mesenchymal stem cells (MSCs) from fetal tissue such as amniotic fluid, chorionic villi and placenta is well-known and a comparison between MSCs originating in different sources such as fetal tissue and those from bone marrow in terms of yield and function is a topical issue. The mesenchymal stem cells isolated from bone marrow are well-characterized. Unfortunately the low quantitative yield during isolation is a major problem. For this reason, other tissue sources for MSCs are of paramount importance. In this review, starting from a description of the molecular and cellular biology of MSCs, we describe alternative sources of isolation other than bone marrow. Finally, we describe the potential therapeutic application of these cells.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAmniotic FluidBone Marrow CellsChorionic VilliFemaleHumansMesenchymal Stem CellsPlacentaPregnancyRegenerative Medicine

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.